TD Cowen raised price targets for GoodRx stock.

The entities involved

• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• Leerink partners →

  U.S. investment bank

  • Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
  • A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38

Related events

• TD Cowen raised its price target on Exelixis shares on August 30, 2026.Aug 30
• TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.Aug 18
• TD Cowen lowered its price target for Navan, Inc. stock on September 10, 2026.Sep 10
• TD Cowen dropped its target price for SAIC stock on August 31, 2026.Aug 31
• TD Cowen lowered its price target on Paychex, while S&P Global Market Intelligence reported a stock decline.Fri 22:09